MyAverix Finance
HK · Healthcare
VISEN Pharmaceuticals (2561)
Drug Manufacturers - Specialty & Generic
VISEN Pharmaceuticals (2561) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $2.67B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2561
VISEN Pharmaceuticals (2561) — FAQ
What is VISEN Pharmaceuticals's market cap?
VISEN Pharmaceuticals (2561) has a reported market cap of $2.67B (data as of 2026-05-21).
What is 2561's P/E ratio?
The price-to-earnings (P/E) ratio for VISEN Pharmaceuticals (2561) is 18.00 (data as of 2026-05-21).
Does VISEN Pharmaceuticals pay a dividend?
Dividend yield is not available in the current snapshot for VISEN Pharmaceuticals (2561). Check the MyAverix Finance app for the latest dividend data.
What sector is VISEN Pharmaceuticals in?
VISEN Pharmaceuticals (2561) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 2561 listed on?
2561 is listed on HK.
What is VISEN Pharmaceuticals's net margin?
VISEN Pharmaceuticals (2561) reports a net margin of 0.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.